196 related articles for article (PubMed ID: 34644709)
1. The Clinical Value of Serum Adropin Level in Early Detection of Diabetic Nephropathy.
Es-Haghi A; Al-Abyadh T; Mehrad-Majd H
Kidney Blood Press Res; 2021; 46(6):734-740. PubMed ID: 34644709
[TBL] [Abstract][Full Text] [Related]
2. Association of Serum Adropin Concentrations with Diabetic Nephropathy.
Hu W; Chen L
Mediators Inflamm; 2016; 2016():6038261. PubMed ID: 27546995
[TBL] [Abstract][Full Text] [Related]
3. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627
[TBL] [Abstract][Full Text] [Related]
4. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.
Zang H; Jiang F; Cheng X; Xu H; Hu X
Endocr J; 2018 Jul; 65(7):685-691. PubMed ID: 29669965
[TBL] [Abstract][Full Text] [Related]
5. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
[TBL] [Abstract][Full Text] [Related]
6. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
8. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
9. Correlation of serum meteorin-like concentrations with diabetic nephropathy.
Wang R; Hu D; Zhao X; Hu W
Diabetes Res Clin Pract; 2020 Nov; 169():108443. PubMed ID: 32946852
[TBL] [Abstract][Full Text] [Related]
10. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
11. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
12. The association of serum and vitreous adropin concentrations with diabetic retinopathy.
Li S; Sun J; Hu W; Liu Y; Lin D; Duan H; Liu F
Ann Clin Biochem; 2019 Mar; 56(2):253-258. PubMed ID: 30514096
[TBL] [Abstract][Full Text] [Related]
13. Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients.
Fouad M; Fathy H; Zidan A
J Bras Nefrol; 2016 Dec; 38(4):403-410. PubMed ID: 28001185
[TBL] [Abstract][Full Text] [Related]
14. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy.
Shelbaya S; Abu Shady MM; Nasr MS; Bekhet MM; Mageed YA; Abbas M
Curr Diabetes Rev; 2018; 14(5):481-486. PubMed ID: 28875825
[TBL] [Abstract][Full Text] [Related]
15. Reduced serum CTRP12 levels in type 2 diabetes are associated with renal dysfunction.
Du J; Xu J; Wang X; Liu Y; Zhao X; Zhang H
Int Urol Nephrol; 2020 Dec; 52(12):2321-2327. PubMed ID: 32734505
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients.
Hu W; Feng P
Diabetes Res Clin Pract; 2011 Feb; 91(2):159-63. PubMed ID: 21144611
[TBL] [Abstract][Full Text] [Related]
17. Serum adropin level is associated with endothelial dysfunction in patients with obstructive sleep apnea and hypopnea syndrome.
Fan Z; Zhang Y; Zou F; Xu T; Pan P; Hu C; Su X
Sleep Breath; 2021 Mar; 25(1):117-123. PubMed ID: 32253609
[TBL] [Abstract][Full Text] [Related]
18. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study.
Al-Rawaf HA; Alghadir AH; Gabr SA
Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum myonectin concentrations in diabetic nephropathy patients.
Zhang J; Hu W; Lin P; Wang R
Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
[TBL] [Abstract][Full Text] [Related]
20. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes.
Suzuki Y; Matsushita K; Seimiya M; Yoshida T; Sawabe Y; Ogawa M; Nomura F
Clin Chem Lab Med; 2012 Oct; 50(10):1833-9. PubMed ID: 23089714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
